In support of this, depletion of CLU, or treatment with verteporfin, an inhibitor of CLU and YAP-signalling, in patient-derived gastric cancer tumorspheres causes apoptosis of gastric cancer stem cells and reduced tumour growth, highlighting the critical pro-survival and oncogenic role of CLU [50]. The gene discussed is YAP1; the disease is gastric cancer.